1. Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial;Group, Scottish Cancer Trials Breast; Unit, I.C.R.F.Breast; Hospital, Guy's; London;Lancet,1993
2. Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction;Shintaku, I.P.; Said, J.W.,1987
3. Estrogen receptor localization in paraffin sections by enzyme digestion, repeated applications of primary antibody, and imidazole;Elias, J.M.; Heimann, A.; Cain, T.; Margiotta, M.; Gallery, F.; Gomes, C.;J Histotechnol,1990
4. Oestrogen and progesterone receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections;Soomro, S.; Shousha, S.; Sinnett, H.D.;Histopathology,1992